
Burcon NutraScience Corporation is seeing a significant rise in its stock price, reflecting positive investor sentiment.
Burcon NutraScience Corporation (BU.TO) has increased by 3.15% today, reaching CA$1.31. This growth comes as the company gains traction in the plant-based protein sector, fueled by strong customer demand and strategic investments.
Advertisement
Burcon NutraScience Corporation
BU.TO
BU.TO
Burcon NutraScience Corporation
Market cap
$16.12M
52W high
$2.75
52W low
$1.25
1W change
-3.79%
Beta
2.83
Analyst Price Targets
Based on analyst covering BU · as of Sep 17, 2026
Wall Street analysts forecast BU stock price to rise 45.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$1.85
+45.7% Upside
Current Price
C$1.27
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BU's historical volatility
30-Day Vol
70.7%
Annualized
90-Day Vol
71.6%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$1.06
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.20 | C$0.94 – C$1.53 |
| 60 trading days | C$1.13 | C$0.80 – C$1.59 |
| 90 trading days | C$1.06 | C$0.70 – C$1.62 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Keep an eye on Burcon's ongoing developments and financial performance as the company shifts from technology development to commercial execution.
Burcon's Market Cap Reaches CA$16.12 Million
With a market cap of CA$16.12 million, Burcon is in the small-cap segment, which presents both opportunities and risks for investors.
Bull case
Burcon recently reported a remarkable 273% year-over-year increase in revenue, reaching CA$1.3 million for the first quarter of fiscal 2027. This growth indicates strong potential, especially as Burcon expands its manufacturing capabilities to meet rising demand for plant-based proteins.
Bear case
Despite the positive trends, investors should be cautious about the company's lack of profitability and the volatility that often comes with small-cap stocks like Burcon.
Advertisement
Strong Revenue Growth Fuels Investor Confidence
Burcon's impressive 273% year-over-year revenue growth shows its increasing commercial traction and customer demand for plant-based protein products. As the company enhances its manufacturing capabilities, investor confidence is likely to grow, supporting the stock's upward trend. For more details on their financial performance, check out the latest results.
Strategic Investments in Manufacturing
In response to strong investor interest, Burcon announced plans to boost its convertible debenture financing, which will strengthen its manufacturing infrastructure. This strategic move aims to take advantage of the growing demand for plant-based proteins, positioning Burcon for sustained growth. Investors should closely monitor these developments, as they could significantly impact the company's future performance. Learn more about their recent financing efforts in the press release.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement

Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.


